Reactive oxygen species-mitochondria pathway involved in LYG-202-induced apoptosis in human hepatocellular carcinoma HepG2 cells

被引:64
作者
Chen, Fei-hong [1 ]
Zhang, Lin-bo [1 ]
Qiang, Lei [1 ]
Yang, Zhen [1 ]
Wu, Tian [1 ]
Zou, Mei-juan [1 ]
Tao, Lei [1 ]
You, Qi-dong [1 ]
Li, Zhi-yu [1 ]
Yang, Yong [1 ]
Guo, Qing-Long [1 ]
机构
[1] China Pharmaceut Univ, Jiangsu Key Lab Carcinogenesis & Intervent, Nanjing 210009, Peoples R China
基金
中国国家自然科学基金;
关键词
Apoptosis; MAPK; Mitochondria; MMP; ROS; CANCER-CELLS; DEATH; ROS; KINASE; DEPOLARIZATION; ACTIVATION; INDUCTION; DECREASE; GROWTH;
D O I
10.1016/j.canlet.2010.04.004
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Previously, we demonstrated that LYG-202, a newly synthesized flavonoid with a piperazine substitution, exhibited obvious antitumor activity in vivo and in vitro. The exact mechanism of this new compound remains unclear. In the present study, we examined the effects of LYG-202 on reactive oxygen species (ROS) production and the downstream signaling pathway in the apoptosis of human hepatocellular carcinoma HepG2 cells. Pretreatment with NAC (N-acetylcysteine), a ROS production inhibitor, partly inhibited the apoptosis induced by LYG-202 via blocking the ROS generation. Further data revealed that LYG-202 induced ROS accumulation followed by a decrease in mitochondrial membrane potential (MMP), release of cytochrome c (Cyt c) and apoptosis-inducing factor (AIF) to cytosol, which induced apoptosis of the cells. Moreover, the mitogen-activated protein kinases (MAPK), the downstream effect of ROS accumulation including c-Jun N-terminal kinase (JNK) and p38 MAPK, could be activated by LYG-202. Taken together, the generation of ROS might play an important role in LYG-202-induced mitochondrial apoptosis pathway, which provided further support for LYG-202 as a novel anticancer therapeutic candidate. (C) 2010 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:96 / 105
页数:10
相关论文
共 27 条
[1]
Direct activation of mitochondrial apoptosis machinery by c-Jun N-terminal kinase in adult cardiac myocytes [J].
Aoki, H ;
Kang, PM ;
Hampe, J ;
Yoshimura, K ;
Noma, T ;
Matsuzaki, M ;
Izumo, S .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (12) :10244-10250
[2]
Decrease in mitochondrial energy couplings by thyroid hormones: a physiological effect rather than a pathological hyperthyroidism consequence [J].
Bobyleva, V ;
Pazienza, TL ;
Maseroli, R ;
Tomasi, A ;
Salvioli, S ;
Cossarizza, A ;
Franceschi, C ;
Skulachev, VP .
FEBS LETTERS, 1998, 430 (03) :409-413
[3]
Mitogen-activated protein (MAP) Kinase/MAP kinase phosphatase regulation: Roles in cell growth, death, and cancer [J].
Boutros, Tarek ;
Chevet, Eric ;
Metrakos, Peter .
PHARMACOLOGICAL REVIEWS, 2008, 60 (03) :261-310
[4]
Stimulation of glyceraldehyde-3-phosphate dehydrogenase by oxyhemoglobin. [J].
Brookes, PS ;
Haley, J ;
Cutler, P ;
Camilleri, P ;
Land, JM ;
Clark, JB ;
Heales, SJR .
BIOCHEMICAL SOCIETY TRANSACTIONS, 1998, 26 (03) :S246-S246
[5]
Hispolon induces apoptosis in human gastric cancer cells through a ROS-mediated mitochondrial pathway [J].
Chen, Wei ;
Zhao, Zhao ;
Li, Ling ;
Wu, Bin ;
Chen, Shi-fei ;
Zhou, Hong ;
Wang, Yong ;
Li, Yong-Quan .
FREE RADICAL BIOLOGY AND MEDICINE, 2008, 45 (01) :60-72
[6]
Rotenone Induces Apoptosis in MCF-7 Human Breast Cancer Cell-Mediated ROS Through JNK and p38 Signaling [J].
Deng, Yea-Tzy ;
Huang, Hsiu-Chen ;
Lin, Jen-Kun .
MOLECULAR CARCINOGENESIS, 2010, 49 (02) :141-151
[7]
Bcl-2 protects against FCCP-induced apoptosis and mitochondrial membrane potential depolarization in PC12 cells [J].
Dispersyn, G ;
Nuydens, R ;
Connors, R ;
Borgers, M ;
Geerts, H .
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 1999, 1428 (2-3) :357-371
[8]
Oxidized protein degradation and repair in ageing and oxidative stress [J].
Friguet, Bertrand .
FEBS LETTERS, 2006, 580 (12) :2910-2916
[9]
Poly(ADPR)potymerase inhibition and apoptosis induction in cDDP-treated human carcinoma cell lines [J].
Gambi, Nadia ;
Tramontano, Filomena ;
Quesada, Piera .
BIOCHEMICAL PHARMACOLOGY, 2008, 75 (12) :2356-2363
[10]
Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways [J].
Ichijo, H ;
Nishida, E ;
Irie, K ;
tenDijke, P ;
Saitoh, M ;
Moriguchi, T ;
Takagi, M ;
Matsumoto, K ;
Miyazono, K ;
Gotoh, Y .
SCIENCE, 1997, 275 (5296) :90-94